Guofeng Tian - Allgens Medical Deputy Director
| 688613 Stock | 17.15 0.22 1.27% |
Director
Guofeng Tian is Deputy Director of Allgens Medical Technology
| Age | 43 |
| Address | No. 5 Kaikai Road, Beijing, China, 100026 |
| Phone | 86 10 5633 0938 |
| Web | https://www.allgensmed.cn |
Allgens Medical Management Efficiency
The company has return on total asset (ROA) of (0.0136) % which means that it has lost $0.0136 on every $100 spent on assets. This is way below average. Allgens Medical's management efficiency ratios could be used to measure how well Allgens Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of February 25, 2025, Total Assets is expected to decline to about 1.1 B. In addition to that, Non Current Assets Total is expected to decline to about 257.9 MSimilar Executives
| Showing other executives | DIRECTOR Age | ||
| An Zhang | Hefei Metalforming Mach | 56 | |
| Li Peng | China Sports Industry | 56 | |
| Aihua Liu | Bloomage Biotechnology Corp | 62 | |
| Xueping Guo | Bloomage Biotechnology Corp | 60 | |
| Wei Zhang | Shandong Hongchuang Aluminum | 43 | |
| Wang Xiaofeng | Hefei Metalforming Mach | 53 | |
| Lingli Lin | Bloomage Biotechnology Corp | 53 | |
| Xiaofeng Wang | Hefei Metalforming Mach | 54 | |
| Jiajun Guo | Bloomage Biotechnology Corp | 50 | |
| Hui Wang | Bloomage Biotechnology Corp | 42 | |
| Shi Chen | China Sports Industry | 51 | |
| Changbo Ke | Rising Nonferrous Metals | 45 | |
| Ningning Xu | China Sports Industry | 44 | |
| Kai Zhu | Shandong Hongchuang Aluminum | N/A | |
| Aihua Wang | Bloomage Biotechnology Corp | 46 | |
| Liang Cai | Sichuan Fulin Transportation | 56 | |
Management Performance
| Return On Equity | 3.0E-4 | ||||
| Return On Asset | -0.0136 |
Allgens Medical Tech Leadership Team
Elected by the shareholders, the Allgens Medical's board of directors comprises two types of representatives: Allgens Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Allgens. The board's role is to monitor Allgens Medical's management team and ensure that shareholders' interests are well served. Allgens Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Allgens Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Guofeng Tian, Deputy Director | ||
| Ling Wang, Head Finance | ||
| Zhiye Qiu, Deputy Secretary | ||
| Gang Hu, Chairman GM | ||
| Menglong Cui, GM Director | ||
| Fuzhai Cui, Founder Scientist | ||
| Wanlan Huang, Deputy Director | ||
| Tianxi Song, Director Manager |
Allgens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Allgens Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 3.0E-4 | ||||
| Return On Asset | -0.0136 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 1.32 B | ||||
| Shares Outstanding | 135.55 M | ||||
| Shares Owned By Insiders | 41.24 % | ||||
| Shares Owned By Institutions | 2.38 % | ||||
| Price To Book | 1.64 X | ||||
| Price To Sales | 12.04 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Allgens Stock
Allgens Medical financial ratios help investors to determine whether Allgens Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allgens with respect to the benefits of owning Allgens Medical security.